Table 3.
USPSTF Grade D Preventive Services by Utilization Volume and Costs
Low-value preventive service | Mean annual count | 95% CI of count | Percent of total utilization | Cost per service | Mean annual cost per service (millions) | 95% CI of costs | Percent of total costs for selected services | Rank by costs | Rank by utilization |
---|---|---|---|---|---|---|---|---|---|
Screening for bacteriuria in asymptomatic adults | 14,144,166 | 12,711,424–15,576,907 | 45.6% | $12 | $169,729,992 | $152,537,088–$186,922,884 | 35.5% | 1 | 1 |
Vitamin D supplementation for primary prevention of fractures among postmenopausal women | 11,911,788 | 10,533,189–13,290,388 | 38.4% | $7 | $83,382,516 | $73,732,323–$93,032,716 | 17.4% | 2 | 2 |
Prostate cancer screening for men 75 years and oldera | 1,786,701 | 1,476,497–2,096,905 | 5.8% | $26 | $46,454,226 | $38,388,922–$54,519,530 | 9.7% | 5 | 3 |
Cervical cancer screening for women over 65 years | 1,403,434 | 1,125,581–1,681,286 | 4.5% | $40 | $56,137,360 | $45,023,240–$67,251,440 | 11.7% | 4 | 4 |
COPD screening among asymptomatic adults | 877,922 | 535,540–1,220,304 | 2.8% | $37 | $32,483,114 | $19,814,980–$45,151,248 | 6.8% | 6 | 5 |
Screening low-risk asymptomatic adults for cardiovascular disease with either rest/stress ECG | 785,939 | 618,449–953,430 | 2.5% | $26 | $20,434,414 | $16,079,674–$24,789,180 | 4.3% | 7 | 6 |
Colon cancer screening over 85 yearsb | 137,441 | 62,736–212,147 | 0.4% | $504 | $69,270,264 | $31,618,944–$106,922,088 | 14.5% | 3 | 7 |
Total | 31,047,391 | 27,063,416–35,031,367 | 100% | $477,891,886 | $377,195,171–$578,589,086 | 100.0% |
aThe Grade D rating for prostate cancer screening among men 75 and older was active from 2008 to 2012, expanded to all men from 2012 to 2018 and revised to men 70 and older in 2018. For consistency in measurement, we applied the 2008–2012 specification across all available years
bThe Grade D rating for colon cancer screening in adults over 85 years of age is currently undergoing USPSTF review for possible revision